Meclofenoxate hydrochloride medicinal composition and method for preparing freeze-drying powder injection of meclofenoxate hydrochloride medicinal composition

A technology of meclofenoxate hydrochloride and its composition, which is applied in the field of drug freeze-dried preparations and its preparation, can solve the problems of large adverse reactions, increased adverse reactions, and decreased clinical curative effect, and achieve excellent curative effect, stable and controllable quality, The effect of simple and easy process

Inactive Publication Date: 2012-07-11
湖北安邦医药有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented new formulation contains two ingredient called melepipolone sodium salt (mevithrophenon) that helps prevent this compound from losing its ability to break down when taken or stored over time without being fully dissolved into water during storage. It also increases the stability and efficiency of other medications by making them more effective at treating certain medical conditions while reducing their negative impacts on patients' healthy tissues.

Problems solved by technology

This patented technical problem addressed by this patents relating to the use of melezfemoral oxidizing agents (MFOs), specifically Meetroquinone). These compounds were found to be very stable but also prone to decomposition during storage due to their strong tendency towards hydrolysis or other instability under certain conditions such as high humidity levels. Additionally, these drugs may cause severe allergic responses if they come into contact with sensitive areas like eyes or skin. Therefore there was a challenge to develop a formulation containing them without causing any harmful issues while maintaining its beneficial properties over time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Meclofenoxate hydrochloride medicinal composition and method for preparing freeze-drying powder injection of meclofenoxate hydrochloride medicinal composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] a. Dissolve 800g of mannitol with 5000ml of water for injection, then add 1000g of meclofenoxate hydrochloride, and adjust the pH value to 4; at room temperature in the dark, add α-cyclodextrin dropwise while stirring, and the stirring time is 5 hours, Make meclofenoxate hydrochloride cyclodextrin saturated solution, the addition of α-cyclodextrin is 5 times of the molar number of meclofenoxate hydrochloride;

[0027] b. In the above solution, add 1000g of reduced glutathione, stir evenly, and then absorb the solution with 0.01% activated carbon, and filter it, the first time with a 0.45um filter membrane, and the second time with a 0.22um filter membrane membrane fine filtration;

[0028] c. Detecting the pH value and content of the filtrate, filling the filtrate after each inspection is qualified, and freeze-drying to obtain the freeze-dried powder injection of the meclofenoxate hydrochloride pharmaceutical composition for injection. The packaging specification is 0....

Embodiment 2

[0029] a. Dissolve 400g of mannitol with 2000ml of water for injection, then add 400g of meclofenoxate hydrochloride, and adjust the pH value to 3; at room temperature in the dark, drop β-cyclodextrin while stirring, and the stirring time is 3 hours to prepare Become meclofenoxate hydrochloride cyclodextrin saturated solution, the addition of β-cyclodextrin is 2 times of the molar number of meclofenoxate hydrochloride;

[0030] b. In the above solution, add 600g of reduced glutathione, stir evenly, and then absorb the solution with 0.01% activated carbon, and filter it, the first time with a 0.45um filter membrane, and the second time with a 0.22um filter membrane membrane fine filtration;

[0031] c. Detecting the pH value and content of the filtrate, filling the filtrate after each inspection is qualified, and freeze-drying to obtain the freeze-dried powder injection of the meclofenoxate hydrochloride pharmaceutical composition for injection. The packaging specification is ...

Embodiment 3

[0033] a. Dissolve 400g of mannitol with 4000ml of water for injection, then add 800g of meclofenoxate hydrochloride, and adjust the pH value to 4; at room temperature in the dark, add γ-cyclodextrin dropwise while stirring, and the stirring time is 4 hours. Make meclofenoxate hydrochloride cyclodextrin saturated solution, the addition of gamma-cyclodextrin is 2 times of the molar number of meclofenoxate hydrochloride;

[0034] b. Add 800g of reduced glutathione to the above solution, stir evenly, then absorb the solution with 0.01% activated carbon, and filter it, the first time with a 0.45um filter membrane, and the second time with a 0.22um filter membrane membrane fine filtration;

[0035] c. Detecting the pH value and content of the filtrate, filling the filtrate after each inspection is qualified, and freeze-drying to obtain the freeze-dried powder injection of the meclofenoxate hydrochloride pharmaceutical composition for injection. The packaging specification is 0.20g...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a meclofenoxate hydrochloride medicinal composition and a method for preparing a freeze-drying powder injection of the meclofenoxate hydrochloride medicinal composition. The meclofenoxate hydrochloride medicinal composition comprises the following components in part by weight: 30 to 100 parts of meclofenoxate hydrochloride, 60 to 120 parts of reduced glutathione and 40 to 80 parts of mannitol. The preparation method comprises the following steps of: a) dissolving the mannitol in water for injection, adding the meclofenoxate hydrochloride, and regulating the pH value to be 2-5; b) adding the reduced glutathione, stirring uniformly, adsorbing the solution by using 0.01 percent active carbon and filtering; and c) performing freeze drying to obtain the freeze-drying powder injection. The meclofenoxate hydrochloride medicinal composition has a reasonable formula and a good curative effect, and is high in quality stability, small in side effects and high in safety, and the adverse reaction of patients on medicine is reduced. The method for preparing the freeze-drying powder injection of the meclofenoxate hydrochloride medicinal composition is reasonable, reliable, simple, feasible, and suitable for industrial production.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 湖北安邦医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap